19.38 1%0.0027% 0.005% 19.38 2,944 23,836,500 1,454 (www.hkeipo.hk) 76,162,000 15,892,0004.79 15 15,892,000 10% 143,018,000 90% 3
19.38 (i)lvc FundsLoyal Valley Capital Advantage Fund LP Loyal Valley Capital Advantage Fund II LP LVC Renaissance Fund LP (ii) Highbury Investment Pte Ltd (iii)(iv) (v)megastar Investment Management Limited (vi)tr Capital III, L.P. (vii) 37,189,00018,190,000 8,489,000 13,339,000 6,063,000 1,212,000 13,339,000 97,821,000 (a) 12.87% (b) 61.56% 2018 9.09 10.04 5(2) LVC Funds 1,160,000 0.73% 10.04 5(2) 5(1)5(2) 10% (a) (b)h 8.08(1) (c) 50% 8.08(3) 8.24 (d) 300 8.08(2) 4
30 2019 1 13 23,836,500 15% www.hkexnews.hk www.junshipharma.com 2018 12 21 www.junshipharma.com www.hkexnews.hk 2018 12 21 www.junshipharma.com www.hkexnews.hk 2018 12 21 2018 12 29 24 www.tricor.com.hk/ipo/result 2018 12 212018 12 28 3691 8488 2018 12 212018 12 27 5
1,000,000 2018 12 21 H 18322 2018 12 21 2018 12 21 1,000,000 2018 12 21 H 183 22 2018 12 21 2018 12 21 6
2018 12 21 2018 12 24 H 2018 12 24 H1,000 H1877 19.38 1%0.0027% 0.005% 19.38 2,944 65% 40% 1,177.60 JS001JS001(i) (ii)iii (iii) (iv)i JS001 7
16% 471.04 (i) UBP1211 I III (ii) JS002 I II III (iii) UBP1213 I II III (iv) 9% 264.96 25% 736.00 10% 294.40 2018 12 14 1,454 76,162,000 15,892,0004.79 20,862,000 1,396 5,000,000.00 20.38 1.0%0.0027% 0.005% 7,946,000 2.63 55,300,000 58 5,000,000.0020.38 1.0%0.0027% 0.005% 7,946,000 6.96 1 50% 7,946,000 8
15 15,892,000 10.00% 143,018,000 90% 19.38 1.0%0.0027% 0.005% 1,000 H (1) (1) LVC Funds 37,189,000 23.40% 4.89% Highbury 18,190,000 11.45% 2.39% 8,489,000 5.34% 1.12% 13,339,000 8.39% 1.75% Megastar Investment 6,063,000 3.82% 0.80% TR III 1,212,000 0.76% 0.16% 13,339,000 8.39% 1.75% 97,821,000 61.56% 12.87% (1) (2) 2018 9
9.09 10.04 5(2) LVC Funds LVC Funds LVC Funds 8.08 18A.07 LVC Funds LVC Funds1,160,000 0.73% (1) (1)(2) 1,160,000 0.73% 0.15% (1) (2) 2018 10.045(2) 10
5(1) 5(2) 10% (a) (b)h 8.08(1) (c) 50% 8.08(3) 8.24 (d) 300 8.08(2) 30 2019 1 13 23,836,500 15% www.hkexnews.hk www.junshipharma.com 11
1,000 579 1,000 H 100.00% 2,000 98 2,000 H 100.00% 3,000 28 3,000 H 100.00% 4,000 115 4,000 H 100.00% 5,000 70 5,000 H 100.00% 6,000 21 5,000 H21 90.48% 91,000 H 7,000 73 5,000 H73 80.43% 461,000 H 8,000 53 5,000 H53 72.17% 411,000 H 9,000 68 5,000 H68 65.03% 581,000 H 10,000 44 5,000 H44 59.55% 421,000 H 20,000 44 10,000 H44 52.39% 211,000 H 30,000 21 13,000 H21 45.08% 111,000 H 40,000 29 16,000 H 40.00% 50,000 61 18,000 H 36.00% 60,000 4 19,000 H4 32.08% 11,000 H 70,000 7 20,000 H7 29.18% 31,000 H 80,000 7 20,000 H7 26.07% 61,000 H 90,000 3 21,000 H3 24.07% 21,000 H 100,000 44 22,000 H 22.00% 200,000 27 40,000 H 20.00% 1,396 12
300,000 15 43,000 H15 14.44% 51,000 H 400,000 11 57,000 H11 14.43% 81,000 H 500,000 14 72,000 H14 14.43% 21,000 H 700,000 3 100,000 H3 14.38% 21,000 H 800,000 1 115,000 H 14.38% 1,000,000 4 143,000 H4 14.38% 31,000 H 1,500,000 2 215,000 H2 14.37% 11,000 H 2,000,000 1 287,000 H 14.35% 3,000,000 3 430,000 H3 14.34% 11,000 H 3,500,000 1 502,000 H 14.34% 4,000,000 1 573,000 H 14.33% 5,000,000 1 716,000 H 14.32% 6,000,000 1 859,000 H 14.32% 58 15,892,000 10% 13
2018 12 21 www.junshipharma.com www.hkexnews.hk 2018 12 212018 12 29 24 www.tricor.com.hk/ipo/result 2018 12 212018 12 28 3691 8488 2018 12 212018 12 27 45 118 28 189 201 636 251 2018 12 21 www.junshipharma.com www.hkexnews.hk 14